Showing results (341-350 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|June 23, 2010
Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactionsG Ahlin, L Chen, L Lazorova, et al.
The Pharmacogenomics Journal|October 27, 2010
Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networksD H Roukos
The Pharmacogenomics Journal|May 28, 2019
Cost-effectiveness analysis of multigene expression profiling assays to guide adjuvant therapy decisions in women with invasive early-stage breast cancerMalek B Hannouf, Gregory S Zaric, Phillip Blanchette, et al.
The Pharmacogenomics Journal|April 12, 2019
A genome-wide association study of tramadol metabolism from post-mortem samplesFrank R Wendt, Anna-Liina Rahikainen, Jonathan L King, et al.
The Pharmacogenomics Journal|August 10, 2016
Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analysesJ M Campbell, M D Stephenson, E Bateman, et al.
The Pharmacogenomics Journal|May 6, 2015
Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritisS B Krintel, C Dehlendorff, M L Hetland, et al.
The Pharmacogenomics Journal|April 22, 2015
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritisA Ferreiro-Iglesias, A Montes, E Perez-Pampin, et al.
The Pharmacogenomics Journal|April 7, 2021
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic modelRika Yuliwulandari, Jae Gook Shin, Erna Kristin, et al.
The Pharmacogenomics Journal|May 6, 2023
Association between functional FCGR3A F158V and FCGR2A R131H polymorphisms and responsiveness to rituximab in patients with autoimmune diseases: a meta-analysisYoung Ho Lee, Gwan Gyu Song
The Pharmacogenomics Journal|July 8, 2015
The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritisM Fabris, L Quartuccio, C Fabro, et al.
Pageof 135